Sana Biotechnology Inc. and UCSF, United States
Work by Dr. Schrepfer is at the forefront of stem immunobiology and paves the way for treatment of a wide range of diseases – from supporting functional recovery of failing myocardium to the derivation of other cell types to treat diabetes, blindness, cancer, lung, neurodegenerative, and related diseases. Her work demonstrates that protecting transplanted cells from immune rejection is the key to unlocking the potential of regenerative medicine.
Dr. Schrepfer is Acting Professor at the Cedars-Sinai Medical Center, and a Scientific Founder and SVP (Head of the Hypoimmune Platform) of Sana Biotechnology, Inc.
MODULATING THE IMMUNE SYSTEM TO FIGHT DISEASE
Thursday, June 12, 2025
2:00 PM – 3:30 PM HK Time
TRANSLATING DISCOVERIES INTO THE CLINIC: OVERCOMING THE ALLOGENEIC TRANSPLANT BARRIER
Thursday, June 12, 2025
3:05 PM – 3:25 PM HK Time